The Ultrasonic Aspirator Market Is Growing with Increasing Prevalence of Neurological Gynecological Disorders
Ultrasonic aspirators are medical devices used in surgical procedures to remove soft tissues or hard tissues, fluid, or air from cavities. Ultrasonic aspirator is also used to fragment the tissue with simultaneous irrigation and aspiration of surgical field. These devices are extensively used in skull base, orbital, lacrimal, and neurological surgeries. Moreover, they allows surgeon to remove tissue selectively and efficiently. Ultrasonic aspirators use low-frequency ultrasonic vibrations to fragment tissue while simultaneously aspirate and irrigate the surgical field. The ultrasonic aspirator market growth is mainly driven by increasing prevalence of neurological gynecological disorders (such as cancer).
According to the National Cancer Institute estimated that, in 2020, around 1,806,590 new cases of cancer will be diagnosed in the United States and 606,520 people will die from the disease. Thus, with increasing prevalence of neurological disorders, such as epilepsy, hydrocephalus, tumors, stroke-related conditions, and traumatic brain injury, demand for ultrasonic aspirator is also increasing, which, in turn, is driving the market ultrasonic aspirator market growth. In April 2019, Stryker launched its Sonopet iQ ultrasonic aspirator system and its SpineMapGo software. Sonopet iQ is designed to allow surgeons to fragment, emulsify, and aspirate soft tissue and bone during complex cranial neurosurgery, spinal, ear, nose, and throat procedures.
In North America, the ultrasonic aspirator market growth is attributed to the increasing product launches and approvals and increasing usage of ultrasonic aspiration in the region. For instance, in June 2020, in July 2020, Integra LifeSciences Holdings Corporation received the Food and Drug Administration (FDA) clearance for a specific indication for neurosurgery for its CUSA Clarity Ultrasonic Surgical Aspirator System. Moreover, in June 2019, Misonix, Inc. received FDA 510(k) clearance for Nexus, its revolutionary ultrasonic aspirator surgical platform. Ultrasonic aspirators help to perform surgeries faster and remove tumors precisely with fewer complications.
Moreover, the increasing adoption of or demand for minimally invasive surgery worldwide is one of the major factor driving the ultrasonic aspirator market growth. According to NCBI findings, around 46,346 minimally invasive surgeries performed for partial nephrectomy in the United States. There is an increasing demand for minimally invasive surgery, as it is associated with a shorter hospital stay, less pain, and fewer complications. Ultrasonic aspirator is widely used for surgical procedures such as tumor resection, gynecology, laparoscopy, and others. However, lack of awareness and high cost associated with ultrasonic aspirator are some of the major factors restraining the ultrasonic aspirator market growth.
Comments
Post a Comment